Concepedia

Dina Shlyakhter

DS

Statistics

Publications

4

Citations

310

H-Index

4

Active since

1997

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Dina Shlyakhter is an author at Vertex Pharmaceuticals (United States) specializing in cellular biochemistry, signal transduction, and autoimmunity.

Top concepts

Publications per year

1997–2015

4

Publications

4

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

Ursula A. Germann, Pamella J. Ford, Dina Shlyakhter et al. · Anti-Cancer Drugs · 1997 · 132 citations

Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes

Jugnu Jain, Susan J. Almquist, Pamella J. Ford et al. · Biochemical Pharmacology · 2003 · 85 citations

, , +8

VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease

Sudipta Mahajan, James K. Hogan, Dina Shlyakhter et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 60 citations

Characterization of Pharmacological Efficacy of VX-148, a New, Potent Immunosuppressive Inosine 5′-Monophosphate Dehydrogenase Inhibitor

Jugnu Jain, Susan J. Almquist, Angela D. Heiser et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 33 citations

1–4 of 4